Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro.
Clinicopathological correlations from human cases and experimental animal studies suggest that neutrophils are critical components of the host response to mucormycosis but that other cellular defense mechanisms appear to be important as well. Since our previous studies demonstrated that Rhizopus oryzae hyphae which are too large to be ingested completely can be damaged and probably killed by human neutrophils, we studied the antihyphal activity of human monocytes. As with neutrophils, light and electron microscopic studies indicated that monocytes attached to hyphae and appeared to destroy them in the absence of serum. As judged by our previously described assay for the leukocyte-induced inhibition of [14C]uracil uptake by hyphae, quantitative damage to hyphae by monocytes was 40.8 +/- 2.2% in 54 experiments. Neither attachment to nor damage of hyphae by monocytes was augmented by the presence of 10% human serum. As with neutrophils, monocyte-mediated damage of R. oryzae was significantly decreased by some inhibitors of oxidative metabolism and scavengers of the potentially microbicidal oxidative leukocyte products, which included 10(-4)M sodium azide, 10 (-3) M sodium cyanide, catalase, 10(-3) M histidine, 10(-3) M tryptophan, and 10(-4) M 1,4-diazobicyclo[2.2.2]octane but not superoxide dismutase, 1.4 X 10(-2) M dimethyl sulfoxide, and 4.0 X 10(-1) M mannitol. Moreover, monocytes from three patients with chronic granulomatous disease failed to damage hyphae at all. In contrast to our previous data for neutrophils, polyanions (10(-5) M polyaspartic or polyglutamic acid) did not inhibit monocyte-mediated hyphal damage. Thus, monocytes can damage and probably kill R. oryzae hyphae by oxidative mechanisms and so may be involved in host defense mechanisms against mucormycosis.
D001386:Azides / Q000494:pharmacology; D002374:Catalase / Q000494:pharmacology; D006105:Granulomatous Disease, Chronic / Q000097:blood; D006639:Histidine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D009000:Monocytes / Q000382:microbiology / Q000502:physiology* / Q000648:ultrastructure; D010879:Piperazines / Q000494:pharmacology; D012233:Rhizopus / Q000502:physiology* / Q000648:ultrastructure; D019810:Sodium Azide; D012966:Sodium Cyanide / Q000494:pharmacology; D014364:Tryptophan / Q000494:pharmacology
D001386:Azides; D010879:Piperazines; D006639:Histidine; D014364:Tryptophan; D019810:Sodium Azide; D002374:Catalase; D012966:Sodium Cyanide; C007306:triethylenediamine